Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load
- PMID: 11739180
- DOI: 10.1182/blood.v98.13.3739
Asymptomatic primary Epstein-Barr virus infection occurs in the absence of blood T-cell repertoire perturbations despite high levels of systemic viral load
Abstract
Primary infection with the human herpesvirus, Epstein-Barr virus (EBV), may result in subclinical seroconversion or may appear as infectious mononucleosis (IM), a lymphoproliferative disease of variable severity. Why primary infection manifests differently between patients is unknown, and, given the difficulties in identifying donors undergoing silent seroconversion, little information has been reported. However, a longstanding assumption has been held that IM represents an exaggerated form of the virologic and immunologic events of asymptomatic infection. T-cell receptor (TCR) repertoires of a unique cohort of subclinically infected patients undergoing silent infection were studied, and the results highlight a fundamental difference between the 2 forms of infection. In contrast to the massive T-cell expansions mobilized during the acute symptomatic phase of IM, asymptomatic donors largely maintain homeostatic T-cell control and peripheral blood repertoire diversity. This disparity cannot simply be linked to severity or spread of the infection because high levels of EBV DNA were found in the blood from both types of acute infection. The results suggest that large expansions of T cells within the blood during IM may not always be associated with the control of primary EBV infection and that they may represent an overreaction that exacerbates disease.
Similar articles
-
Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.J Virol. 2017 Oct 13;91(21):e00382-17. doi: 10.1128/JVI.00382-17. Print 2017 Nov 1. J Virol. 2017. PMID: 28835490 Free PMC article.
-
Fluorescence in situ hybridization is superior for monitoring Epstein Barr viral load in infectious mononucleosis patients.BMC Infect Dis. 2017 May 3;17(1):323. doi: 10.1186/s12879-017-2412-y. BMC Infect Dis. 2017. PMID: 28468603 Free PMC article.
-
Comprehensive assessment of peripheral blood TCRβ repertoire in infectious mononucleosis and chronic active EBV infection patients.Ann Hematol. 2017 Apr;96(4):665-680. doi: 10.1007/s00277-016-2911-8. Epub 2017 Jan 14. Ann Hematol. 2017. PMID: 28091735
-
Virological aspects of Epstein-Barr virus infections.Acta Med Okayama. 2005 Dec;59(6):239-46. doi: 10.18926/AMO/31961. Acta Med Okayama. 2005. PMID: 16418766 Review.
-
Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.Semin Cancer Biol. 2008 Dec;18(6):397-408. doi: 10.1016/j.semcancer.2008.10.008. Epub 2008 Oct 25. Semin Cancer Biol. 2008. PMID: 18977445 Review.
Cited by
-
Epstein-Barr virus, interleukin-10 and multiple sclerosis: A ménage à trois.Front Immunol. 2022 Oct 7;13:1028972. doi: 10.3389/fimmu.2022.1028972. eCollection 2022. Front Immunol. 2022. PMID: 36275700 Free PMC article.
-
Vaccine Development for Epstein-Barr Virus.Adv Exp Med Biol. 2018;1045:477-493. doi: 10.1007/978-981-10-7230-7_22. Adv Exp Med Biol. 2018. PMID: 29896681 Free PMC article. Review.
-
Progress and problems in understanding and managing primary Epstein-Barr virus infections.Clin Microbiol Rev. 2011 Jan;24(1):193-209. doi: 10.1128/CMR.00044-10. Clin Microbiol Rev. 2011. PMID: 21233512 Free PMC article. Review.
-
The privacy of T cell memory to viruses.Curr Top Microbiol Immunol. 2006;311:117-53. doi: 10.1007/3-540-32636-7_5. Curr Top Microbiol Immunol. 2006. PMID: 17048707 Free PMC article. Review.
-
Heterologous immunity between viruses.Immunol Rev. 2010 May;235(1):244-66. doi: 10.1111/j.0105-2896.2010.00897.x. Immunol Rev. 2010. PMID: 20536568 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources